Skip to main content

Table 3 Potential cyclin D1 peptides for HLA-A*0201 molecules

From: A novel vaccine for mantle cell lymphoma based on targeting cyclin D1 to dendritic cells via CD40

Name

Sequence

Length (mer)

Predictive binding score a

P5-13

LLCCEVETI

9

6.0

P63-71

WMLEVVCEEQ

9

947.8

P151-159

NLAAMTPHD

9

743.7

P202-210

MVAAGSVVA

9

854.6

P204-212

AAGSVVAAV

9

703.7

P4-13

QLLCCEVETI

10

133.6

P21-30

NLLNDRVLRA

10

324.3

P58-67

KIVATWMLEV

10

255.9

P100-109

QLLGATCMFV

10

8.3

P101-110

LLGATCMFVA

10

184.0

P123-132

KLCIYTDNSI

10

246.9

P154-163

AMTPHDFIEH

10

981.0

P164-173

FLSKMPEAEE

10

508.5

P203-212

VAAGAVVAAV

10

580.3

P253-262

ALLESSLRQA

10

474.4

P57-67

RKIVATWMLEV

11

354.3

P94-104

VKKSRLQLLGA

11

582.3

P99-109

LQLLGATCMFV

11

711.1

P106-116

CMFVASKMKET

11

339.2

P123-133

KLCIYTDNSIR

11

362.3

P154-164

AMTPHDFIEHF

11

904.8

P158-168

HAFIEHFLSKM

11

577.7

P202-212

MVAAGSVVAAV

11

746.2

P208-218

VVAAVQGLNLR

11

442.9

  1. aPredictions (ann methods)—low IC50 values (nM) = good binder.